This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, H. L.-Y.
Right arrow Articles by Sung, J. J.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, H. L.-Y.
Right arrow Articles by Sung, J. J.-Y.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2003, p. 1277-1279, Vol. 41, No. 3
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.3.1277-1279.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Hepatitis B Virus Genotype C Takes a More Aggressive Disease Course Than Hepatitis B Virus Genotype B in Hepatitis B e Antigen-Positive Patients

Henry Lik-Yuen Chan,* May Ling Wong, Alex Yui Hui, Lawrence Cheung-Tsui Hung, Francis Ka-Leung Chan, and Joseph Jao-Yiu Sung

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong SAR, People’s Republic of China

Received 1 July 2002/ Returned for modification 28 September 2002/ Accepted 8 December 2002

One hundred forty-six hepatitis B e antigen (HBeAg)-positive chronic hepatitis B patients were followed up for 32 ± 13 months. All six patients with hepatocellular carcinoma had hepatitis B virus (HBV) genotype C. Disease activity was greater in patients infected by HBV genotype C than in those infected by HBV genotype B in the HBeAg-positive phase but not after HBeAg seroconversion.


* Corresponding author. Present address: Department of Medicine and Therapeutics, 9/F Prince of Wales Hospital, Shatin, New Territories, Hong Kong. Phone: 852-2632-3616. Fax: 852-2637-5396. E-mail: hlychan{at}hotmail.com.


Journal of Clinical Microbiology, March 2003, p. 1277-1279, Vol. 41, No. 3
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.3.1277-1279.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Lusida, M. I., Nugrahaputra, V. E., Soetjipto, , Handajani, R., Nagano-Fujii, M., Sasayama, M., Utsumi, T., Hotta, H. (2008). Novel Subgenotypes of Hepatitis B Virus Genotypes C and D in Papua, Indonesia. J. Clin. Microbiol. 46: 2160-2166 [Abstract] [Full Text]  
  • Chan, H. L.-Y., Tse, C.-H., Mo, F., Koh, J., Wong, V. W.-S., Wong, G. L.-H., Lam Chan, S., Yeo, W., Sung, J. J.-Y., Mok, T. S.-K. (2008). High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular Carcinoma. JCO 26: 177-182 [Abstract] [Full Text]  
  • Laperche, S., Thibault, V., Bouchardeau, F., Alain, S., Castelain, S., Gassin, M., Gueudin, M., Halfon, P., Larrat, S., Lunel, F., Martinot-Peignoux, M., Mercier, B., Pawlotsky, J.-M., Pozzetto, B., Roque-Afonso, A.-M., Roudot-Thoraval, F., Saune, K., Lefrere, J.-J. (2006). Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study.. J. Clin. Microbiol. 44: 3600-3607 [Abstract] [Full Text]  
  • Chan, H. L.-Y., Tse, C.-H., Ng, E. Y.-T., Leung, K.-S., Lee, K.-H., Tsui, S. K.-W., Sung, J. J.-Y. (2006). Phylogenetic, Virological, and Clinical Characteristics of Genotype C Hepatitis B Virus with TCC at Codon 15 of the Precore Region.. J. Clin. Microbiol. 44: 681-687 [Abstract] [Full Text]  
  • Chan, H. L.-Y., Leung, N. W.-Y., Hui, A. Y., Wong, V. W.-S., Liew, C.-T., Chim, A. M.-L., Chan, F. K.-L., Hung, L. C.-T., Lee, Y.-T., Tam, J. S.-L., Lam, C. W.-K., Sung, J. J.-Y. (2005). A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-{alpha}2b and Lamivudine with Lamivudine Alone. ANN INTERN MED 142: 240-250 [Abstract] [Full Text]  
  • Chan, H L-Y, Hui, A Y, Wong, M L, Tse, A M-L, Hung, L C-T, Wong, V W-S, Sung, J J-Y (2004). Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53: 1494-1498 [Abstract] [Full Text]  
  • Chan, H. L.-Y., Wong, M. L., Hui, A. Y., Hung, L. C.-T., Chan, F. K.-L., Sung, J. J.-Y. (2003). Use of Hepatitis B Virus DNA Quantitation To Predict Hepatitis B e Antigen Reversion in Cases of Chronic Hepatitis B. J. Clin. Microbiol. 41: 4793-4795 [Abstract] [Full Text]